Key result
White adipose tissue acts as a major endocrine organ, releasing inflammation-related adipokines that contribute to chronic mild inflammation and the development of obesity-linked diseases.
Highlights the role of white adipose tissue as an endocrine organ that secretes adipokines, contributing to chronic inflammation and metabolic diseases in obesity.
Answers are grounded in this paper and cite their sources.
Supports adipokine-focused strategies in obesity care; leaves open targeted interventions for prospective validation.
White adipose tissue (WAT) is a major endocrine and secretory organ, which releases a wide range of protein signals and factors termed adipokines. A number of adipokines, including leptin, adiponectin, tumour necrosis factor alpha, IL-1beta (interleukin 1beta), IL-6, monocyte chemotactic protein-1, macrophage migration inhibitory factor, nerve growth factor, vascular endothelial growth factor, plasminogen activator inhibitor 1 and haptoglobin, are linked to inflammation and the inflammatory response. Obesity is characterized by a state of chronic mild inflammation, with raised circulating levels of inflammatory markers and the expression and release of inflammation-related adipokines generally rises as adipose tissue expands (adiponectin, which has anti-inflammatory action is an exception). The elevated production of inflammation-related adipokines is increasingly considered to be important in the development of diseases linked to obesity, particularly Type II diabetes and the metabolic syndrome. WAT is involved in extensive cross-talk with other organs and multiple metabolic systems through the various adipokines.
No takes yet. Share an insight, caveat, or question.
Trayhurn et al. (2005) conducted a review in Obesity. White adipose tissue acts as a major endocrine organ, releasing inflammation-related adipokines that contribute to chronic mild inflammation and the development of obesity-linked diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: